A detailed history of Bell Investment Advisors, Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 27 shares of VIR stock, worth $199. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 27 -0.0%
Holding current value
$199
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$9.14 - $24.62 $438 - $1,181
-48 Reduced 64.0%
27 $0
Q2 2023

Aug 09, 2023

SELL
$23.2 - $27.29 $533 - $627
-23 Reduced 23.47%
75 $1,000
Q4 2022

Feb 08, 2023

BUY
$19.96 - $28.22 $898 - $1,269
45 Added 84.91%
98 $2,000
Q3 2022

Nov 09, 2022

BUY
$18.26 - $31.1 $164 - $279
9 Added 20.45%
53 $1,000
Q2 2022

Aug 12, 2022

BUY
$19.08 - $26.7 $381 - $534
20 Added 83.33%
44 $1,000
Q4 2021

Feb 14, 2022

BUY
$30.97 - $54.03 $371 - $648
12 Added 100.0%
24 $1,000
Q3 2021

Nov 12, 2021

BUY
$34.9 - $54.54 $418 - $654
12 New
12 $1,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $979M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.